Investigation of Reduction of Blood Pressure and Metabolic Rate in Obese Hypertensive Patients Using Eplerenone: Implications for Treatment of Hypertension and Heart Failure.
Phase of Trial: Phase II
Latest Information Update: 05 May 2014
At a glance
- Drugs Eplerenone (Primary) ; Amlodipine
- Indications Hypertension
- Focus Pharmacodynamics
- 10 Mar 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jan 2014 According to ClinicalTrials.gov record, planned end date changed from 1 Oct 2012 to 1 Oct 2015.
- 10 Apr 2012 Planned end date changed from 1 Jan 2011 to 1 Oct 2012 as reported by ClinicalTrials.gov.